Cannabis in the City: Developments in Local Cannabis Regulation in Europe

Total Page:16

File Type:pdf, Size:1020Kb

Cannabis in the City: Developments in Local Cannabis Regulation in Europe Cannabis in the City: Developments in local cannabis regulation in Europe ideas into movement AUTHORS: Tom Blickman, Katie Sandwell, and Dania Putri; Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel This report draws on, and in parts reproduces, country reports written by Tom Decorte (Belgium); Vibeke Asmussen Frank & Maj Nygaard-Christensen (Denmark); Ingo Ilja Michels, Tim Pfeiffer-Gerschel, Heino Stöver & Bernd Werse (Germany); Dirk J. Korf (Netherlands); Xabier Arana (Spain); and Frank Zobel (Switzerland). These reports were produced as part of the New Approaches in Harm Reduction Policies and Practices project. EDITOR: Deborah Eade DESIGN: Guido Jelsma - www.guidojelsma.nl PUBLICATION DETAILS: Contents of the report may be quoted or reproduced for non-commercial purposes, provided that the source of information is properly cited. This project has been funded with support from the European Commission. This publication reflects the views only of the author, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. TRANSNATIONAL INSTITUTE (TNI) De Wittenstraat 25, 1052 AK Amsterdam, The Netherlands Tel: +31-20-6626608, Fax: +31-20-6757176 E-mail: [email protected] www.tni.org/drugs @DrugLawReform Drugsanddemocracy Amsterdam, March 2019 2 | Cannabis in the City: Developments in local cannabis regulation in Europe transnationalinstitute Contents Cannabis and International Law 5 Policy Proposal: Regulated cannabis markets in Canada 6 The European Dimension 8 The Dutch Experience and International Law 10 Introduction to the Country Contexts 12 Belgium 13 Denmark 15 Germany 16 Netherlands 18 Policy Proposal: Summary of proposals for local regulation of the ‘back door’ in the 20 Netherlands Spain 21 Switzerland 23 Policy Proposal Berne: Safer Cannabis Research in Pharmacies Trial 25 Policy Spaces 26 Prosecutorial Discretion 26 Exploring the Extent of Municipal and Regional Powers –Regional regulation 30 Netherlands 30 Denmark 31 Policy Proposal: The Dutch Experiment 31 Policy Proposal: The Copenhagen Model 32 Germany 32 Spain 33 Switzerland 35 Policy Proposal: Basel-City 36 Belgium 36 Regulatory Matters and Definitions of Substances 37 Medicinal Cannabis 38 Political Levers: Pathways to national-level change or increased policy space 39 Advocacy by Municipalities and Other Local Authorities 39 Ballot Initiatives and Referenda 40 Expert Opinions and Advisory Bodies 41 Parliamentary (and Other Legislative) Initiatives 42 Non-State Actors 43 Civil Society Advocacy 43 Bottom-up Initiatives from Civil Society 44 Strategic Litigation and Legal Intervention 46 A Possible Framework for Moving Forward: From top-down to bottom-up 49 The National Level: Local Customisation 50 The EU Level: Multi-Level Governance 50 The UN Level: Inter-Se Modification 52 Conclusions 52 transnationalinstitute Cannabis in the City: Developments in local cannabis regulation in Europe | 3 In the last decade, there have been clear some cases, high financial costs associated signs of a shift in governments’ approaches with enforcing prohibitionist drug legislation to recreational cannabis markets. Countries and confronting dangerous methods of illicit including Uruguay and, more recently, Canada cultivation, the impacts of drug policies are – as well as a number of US states – have felt at the local, municipal, and regional moved to control cannabis through regulated level. Because of their unique relation to drug markets rather than prohibition. Proponents policy and a tendency to approach drug issues of this approach argue that prohibition has pragmatically rather than primarily as issues been largely ineffective in reducing cannabis of political or moral principle, cities have consumption, and has been linked to historically been important in championing significant negative impacts, including (often new drug policies. For example, in the 1990s, racialised) mass incarceration of drug users, European cities, organised into European threats to public health, high enforcement Cities on Drug Policy (ECPD), were crucial costs, and young people’s unrestricted access advocates of the harm-reduction based to cannabis via criminal markets. Proponents responses to the heroin crisis mentioned of regulation argue that controlled markets above. are safer: they allow governments to more effectively keep drugs out of the hands of Although cities and regional authorities minors; better protect cannabis users from may have some powers related to the being exposed to adulterated or contaminated implementation of drug policy, they often drugs, or to other ‘harder’ drugs, through feel shackled by national law, unable to act black markets and criminal suppliers; and directly to change policy. For this reason, would reduce the proceeds of criminal groups they have focused considerable energy on involved in the drug trade. However, after advocating some degree of reform of national decades of relatively progressive drug policy, laws that limit their ability to deal creatively Europe seems to be lagging behind the rest of with cannabis-related issues in their the world in relation to cannabis. jurisdictions. National governments, however, have generally been slow to respond to these During the linked crises of HIV and AIDS demands. States themselves have only limited and heroin in the 1990s, many European opportunities for reform, as they are bound governments adopted harm-reduction by international obligations stemming from models, reforming their national drug the United Nations (UN) conventions on drug policies in terms of public health. Since the control and other treaties and agreements. mid-1990s and early 2000s, however, the This has created something of an impasse focus of European drug policy seems to have in the area of cannabis reform, which actors shifted towards security, criminality and across Europe are trying to break in order to disorder. Since cannabis use is widespread develop more efficient, effective, and locally in many countries, and local production and adapted cannabis policies. distribution involves the black market and is often controlled by organised crime, this This paper examines six European shift has put cannabis policy back on the countries – Belgium, Denmark, Germany, agenda. Some jurisdictions have responded the Netherlands, Spain and Switzerland by reinforcing prohibitionist policies, while a – in order to better understand the tools number of regions, municipalities, and other being used – and the challenges faced – by sub-national jurisdictions are advocating municipal and regional governments calling regulation rather than prohibition. for different cannabis policies. Although the national contexts, histories, legislation, Around Europe, large cities in particular often state structures, and social contexts of bear the brunt of national drug policies. While these countries vary significantly, there are municipal and regional governments have important lessons to be learned by comparing limited power to influence national criminal different approaches. This paper draws on law, and therefore key elements of drug Country Reports (published separately) policy, cities and regions have to deal with the which were written by researchers within effects of these laws. From public nuisance each country, which offer a more detailed and disturbances caused by street dealing, to exploration of the respective reform efforts, social or public health issues resulting from as well as of the national political and policy unrestricted youth access to cannabis, to, in environment. 4 | Cannabis in the City: Developments in local cannabis regulation in Europe transnationalinstitute The picture that emerges from this research is Furthermore, while it may be less politically one of municipalities and regions struggling inflammatory for national governments to within restrictive policy frameworks. ‘turn a blind eye’ to changes at the sub- This report opens with a discussion of the national level, tacitly allowing them without combined challenges that have created the making corresponding changes to national current impasse in cannabis regulation at the law – the policy so far pursued by the United UN, European Union (EU), and national level. States – the principles of international law This is followed by a short introduction to the suggest that this does not avoid the relevant history and context of cannabis regulation legal issues.1 International treaties require and reform in each of the six countries, and countries to implement commitments some of the research findings. In short, throughout their territory, and are not we have identified two primary routes to sensitive to internal domestic jurisdictional reform which are currently being pursued distinctions, as the overarching 1969 Vienna by regional or municipal governments in the Convention on the Law of Treaties (VCLT) six countries. Although government actors stipulates: ‘a treaty is binding upon each may try to make direct changes to national party in respect of its entire territory’ (Article drug law, there are a number of spaces where 29).2 The 1961 Single Convention on Narcotic they may, either autonomously or with the Drugs, the foundation of today’s UN drug support of national governments, make control system, also specifies that it applies direct changes to drug policy without major ‘to all non-metropolitan territories
Recommended publications
  • WHO Expert Committee on Drug Dependence Pre-Review ……………
    WHO Expert Committee on Drug Dependence Pre-Review …………….. Cannabis plant and cannabis resin Section 5: Epidemiology This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization 1 © World Health Organization 2018 All rights reserved. This is an advance copy distributed to the participants of the 40th Expert Committee on Drug Dependence, before it has been formally published by the World Health Organization. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.
    [Show full text]
  • Texto Completo Libro (Pdf)
    LAS SENDAS DE LA REGULACIÓN DEL CANNABIS EN ESPAÑA Consejo editorial María Eugenia Aubet - Manuel Cruz Rodríguez - Josep M. Delgado Ribas - Oscar Guasch Andreu - Antonio Izquierdo Escribano - Raquel Osborne - R. Lucas Platero - Oriol Romaní Alfonso - Amelia Sáiz López - Verena Stolcke - Olga Viñuales Sarasa Serie General Universitaria - 191 REGULACIÓN RESPONSABLE (ed.) LAS SENDAS DE LA REGULACIÓN DEL CANNABIS EN ESPAÑA Editor académico: David Pere Martínez Oró edicions bellaterra Diseño de la colección: Joaquín Monclús © Sus autores, 2017 © Regulación responsable, 2017 © David Pere Martínez Oró, 2017 © Edicions Bellaterra, S.L., 2017 Navas de Tolosa, 289 bis. 08026 Barcelona www.ed-bellaterra.com Quedan prohibidos, dentro de los límites establecidos en la ley y bajo los apercibimientos legalmente previstos, la reproducción total o parcial de esta obra por cualquier medio o procedimiento, ya sea electrónico o mecánico, el tratamiento informático, el alquiler o cualquier otra forma de cesión de la obra sin la autorización previa y por escrito de los titulares del copyright. Diríjase a CEDRO (Centro Español de Derechos Reprográficos, http://www.cedro.org) si necesita fotocopiar o escanear algún fragmento de esta obra. Impreso en España Printed in Spain ISBN: 978-84-7290-809-3 Depósito Legal: B. 6.579-2017 Impreso por Prodigitalk. Martorell (Barcelona) Índice Autores, 15 Presentación, 25 A modo de prólogo. Las sendas de la regulación del cannabis en Es- paña, 27 BLOQUE I Los consumos de cannabis en clave sociocultural 1. Cannabis en España. Continuidades y puntos de inflexión históri- cos, 33 Desde la Antigüedad a la Edad Moderna, 33 • Exotismo, literatura y terapéutica durante el siglo XIX y primer tercio del XX, 35 • El Protec- torado de la Zona de Marruecos y la guerra civil, 37 • Los grifotas del franquismo, 38 • Transición y consolidación democrática, 40 • Refe- rencias bibliográficas, 43 2.
    [Show full text]
  • Cannabis Dictionary
    A MEDICAL DICTIONARY, BIBLIOGRAPHY, AND ANNOTATED RESEARCH GUIDE TO INTERNET REFERENCES JAMES N. PARKER, M.D. AND PHILIP M. PARKER, PH.D., EDITORS ii ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright 2003 by ICON Group International, Inc. Copyright 2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1 Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation.
    [Show full text]
  • Hoe Begin Ik Een
    HOW TO SET UP A CSC IN 4 STEPS Presentation by Joep Oomen, Encod SPAIN • Since 2005, approx. 200 clubs have been set up • Legal basis: cultivation for personal use is not prosecuted • Some clubs have thousands of members, consumption room, open daily • One Spanish village (Rasquera, Catalonia) is ready to produce for CSC’s, regional authorities are considering legal regulation for clubs • www.fac.cc BELGIUM • One CSC: Trekt Uw Plant, operating since 2010 • Legal basis: ministerial guideline allowing 1 plant per adult • TUP has 300 members, 2 regional sections • 14 growers, with a max. of 32 plants each • Every 2/3 months: harvest • Information on homegrowing, healthier ways of growing and consuming, lobby for cannabis regulation • www.trektuwplant.be FRANCE • Initiative to organise collectives who wish to work along the CSC guidelines since July 2012 • Legal basis: none – it is an act of civil disobedience • 150 initiatives around the country, first meeting to agree on common principles in december 2012 • Facebook: Cannabis Social Club Français GERMANY • Facebook page to promote the idea • Legal basis: none – it is an act of civil disobedience • In February 2012, a hearing on CSC’s took place in German parliament • Facebook: Pro Cannabis Social Club's für Deutschland UNITED KINGDOM • Website to promote the idea • Legal basis: none – it is an act of civil disobedience • Some 50 clubs exist on the website – unclear if they are active or not • www.cannabiscure.co.uk ITALY • Several initiatives to open the discussion • Legal basis: none –
    [Show full text]
  • How Can the Lens of Human Rights Provide a New Perspective on Drug Control and Point to Different Ways of Regulating Drug Consumption?
    How can the lens of human rights provide a new perspective on drug control and point to different ways of regulating drug consumption? A thesis submitted to The University of Manchester for the degree of Doctor of Philosophy in the Faculty of Humanities 2015 Melissa L. Bone School of Law Table of Contents Index of Tables……………………………………………………………………..….5 Table of Cases………………………………………….………………………………6 Table of Statutes, Treaties and Legislative Instruments……………………………....10 List of Abbreviations…………………………………………………………………15 Abstract………………………………………………...…………………………….18 Candidate’s Declaration and Copyright Statement…………………………………...19 Acknowledgements…………………………………...……………………………...20 Introduction………………………………………………………………..…………22 Chapter 1: Understanding the origin and value of human rights and psychoactive consumption………………………………………………………………………….32 1.1 What are human rights and where have they come from?………..……………….33 1.2 Human right foundations and the question of importance…………...……………36 1.3 The grounds for human rights…………………………………………….………42 1.3.1 ‘The universalist challenge’…………………………………………..46 1.4 The origin and value of human psychoactive consumption……………………….49 1.5 Conclusion……………………………………………………………..…………54 Chapter 2: Understanding how human rights can address the drug policy binary: the conflict between the interests of the State and the interests of the individual………….55 2.1 Defining ‘the State’……………………………………………………...………..56 2.2 Identifying four ‘typical philosophical positions and the binary which underpins them……………………………………………………………….………………….62
    [Show full text]
  • PDF (Book of Abstracts)
    Ninth Annual Conference of the International Society for the Study of Drug Policy Ghent (Belgium) – 20 – 22 May 2015 Venue: Het Pand With the financial support of Book of Abstracts i ISSDP conference 20-22 May 2015 Book of Abstracts Table of Contents KEYNOTE SPEAKERS ......................................................................................................................................... 5 ABDOOL, REYCHAD ................................................................................................................................................ 6 BERRIDGE, VIRGINIA .............................................................................................................................................. 7 KRAUS, LUDWIG .................................................................................................................................................... 8 MASAO, FRANK ..................................................................................................................................................... 9 MOORE, DAVID ................................................................................................................................................... 10 TOUFIQ, JALLAL ................................................................................................................................................... 11 ORAL PRESENTATIONS ................................................................................................................................... 13 AHMED, TANVIR
    [Show full text]
  • Drug Law Reform: Moving Beyond Strict Criminal Penalties for Drugs
    Drug law reform: Moving beyond strict criminal penalties for drugs Professor Simon Lenton Deputy Director, NDRI Introduction The term ‘decriminalisation’ can confuse the discussion about drug policy reform as it means so many different things to different people. Indeed many confuse ‘decriminalisation’ with ‘legalisation’, that is, making some aspect of the drug possession/use no longer an offence. More correctly, the term is used to refer to refer to what is termed prohibition with civil penalties, that is, much like speeding in a motor vehicle – illegal, not condoned, but only attracting civil penalties like a fine, with no further criminal actions taken if the fine is paid by the due date. It is likely that others use it as a generic term meaning reducing penalties in comparison to total prohibition with strict criminal penalties. The confusion about what decriminalisation means is problematic for a number of reasons. Firstly, sensible discussion of drug policy options is impossible when the meanings of terms aren’t shared. Secondly, we tend to be scared of what we don’t understand. Consequently, it is unsurprising that the latest Nielsen poll has found that public support for ‘decriminalisation’ is low, at only 27% (1). Previously it has been found that when the term was explained, support for applying prohibition with civil penalties to cannabis use increased from 64% to 72% (2). According to the National Drug Strategy Survey Australian public support for criminal penalties for possession of cannabis has remained low, ranging from 34% to 39%, in the four surveys conducted between 2001 and 2010. Interestingly, support for legalisation of cannabis use has been even lower declining from 31% in 2001 to 25% in 2010.
    [Show full text]
  • Cannabis Regulation in Europe: Country Report Denmark
    COUNTRY REPORT | February 2019 Cannabis Regulation in Europe: Country Report Denmark Maj Nygaard-Christensen and Vibeke Asmussen Frank Aarhus University ideas into movement Introduction This report examines policy and practice relating to the regulation of cannabis in Denmark. It was produced as part of a study of cannabis regulation models in Europe, funded by the European Commission and led by the Transnational Institute in Amsterdam. The broader study examines and compares experiences from European countries’ experiments with cannabis regulation, including trial proposals for legalisation or decriminalisation of cannabis use, with a particular focus on larger cities in six countries. Denmark has no legal regulation regarding recreational cannabis use, and possession, production, import/export, and buying and selling of cannabis is illegal (Dahl and Frank 2012: 13). This overview of the legal and policy framework for the regulation of cannabis first introduces the policy shifts in cannabis control in Denmark, reviews the political positions on possibilities for legalisation or decriminalisation, and the international context influencing these. It then offers an analysis of how policy and police crackdowns on the open-air cannabis market in Christiania in Copenhagen led to a dispersal and restructuring of the market, with the entry of new criminal gangs. This part of the report indicates an increasingly repressive cannabis policy in Denmark, although there are some openings in the form of a trial for medicinal cannabis commencing in 2018, and a proposed model for legalised cannabis in Copenhagen Municipality. From Tolerant to Repressive Cannabis Control Cannabis falls under the 1955 Euphoriant Substances Act, which is used for minor offences that can be punished with up to a two-year prison term, and the penal code’s §191 from 1969, which refers to the organised sale and possession of larger amounts of narcotics.
    [Show full text]
  • A Research Agenda for the Regulation of Non-Medical Cannabis Use in Switzerland
    A RESEARCH AGENDA FOR THE REGULATION OF NON-MEDICAL CANNABIS USE IN SWITZERLAND Commissioned by the Federal Office of Public Health Roman Zwicky, Palmo Brunner, Flavia Caroni, Daniel Kübler Zürcher Politik- & Evaluationsstudien Nr. 20, May 2021 Zürcher Politik- & Evaluationsstudien herausgegeben von Thomas Widmer Publikationsreihe des Forschungsbereichs ‚Policy-Analyse & Evaluation’ Institut für Politikwissenschaft, Universität Zürich Projektinformation: Auftraggeberin: Bundesamt für Gesundheit (BAG) Sektion wissenschaftliche Grundlagen 3003 Bern E-Mail: [email protected] Vertragsnummer: 20.011294 Laufzeit: November 2020 – Mai 2021 Leitung Forschungsprojekt im BAG: Marc Wittwer, Sektion wissenschaftliche Grundlagen Originalsprache: Englisch Zitiervorschlag: ZWICKY, Roman, BRUNNER, Palmo, CARONI, Flavia & KÜBLER, Daniel (2021):A Research Agenda for the Regulation of Non-Medical Cannabis Use in Switzerland. Zurich, Department of Political Science (Zürcher Politik- und Evaluationsstudien Nr. 20) ISBN 3-908610-43-7 Bezugsadresse: Universität Zürich Institut für Politikwissenschaft Forschungsbereich Policy-Analyse & Evaluation Affolternstrasse 56, CH-8050 Zürich Telefon +41 1 634 38 41 E-Mail [email protected] © 2021 bei den Autorinnen und Autoren und beim Bundesamt für Gesundheit Table of Contents A Research Agenda for the Regulation of Non-Medical Cannabis Use in Switzerland Table of Contents Executive summary 5 Zusammenfassung 15 Résumé 27 Sintesi 38 1 Introduction 49 1.1 Background: Cannabis policy in Switzerland 49 1.2 Mandate
    [Show full text]
  • A Bottom up Proposal for a Regulated Cannabis Market
    A BOTTOM UP PROPOSAL FOR A REGULATED CANNABIS MARKET By Joep Oomen, European Coalition for Just and Effective Drug Policies Wellcome and thanks for the invitation…. Encod is convinced that a Europe with peace, prosperity, personal rights and freedoms, effective governance, policies aimed at solving problems and not at creating them, is a Europe where the drugsmarket has been regulated. The lack of a legal framework with regards to drugs is one of the pillars of a system that essentially denies human beings legal access to products (some of them even natural products) which are benefitial to their health, physical or mental. Among the many disasters that prohibition of cannabis and other drugs has produced, maybe the worst is that it has destroyed this access, and instead established a market that is almost entirely driven by economic reasons, without taking into account the rights of consumers and producers. This lack of framework is deliberately maintained so on the one hand, power structures can continue to feed themselves with money gained from desperacy, while on the other, power structures can continue to justify fargoing control and intrusion in people’s private life. Drug prohibition is serving the needs of the elite, and therefore it will not be the elite that will be able to stop it. If we want to replace this policy with a sound and healthy alternative, we need to build it ourselves, bottom up. Since more than a decade, citizens allover Europe have started to use the loopholes in the absurd drug law to create this alternative. Wellcome to the Cannabis Social Club! Cannabis Social Clubs organise the collective cultivation of an amount of cannabis that is exclusively meant for the private consumption of their members.
    [Show full text]
  • Drugs, Crime and Statistics a Hangover for Life Prison Needle Exchange Controversy Quit Or Die, You Have Another Choice Contents
    Drugs, crime and statistics A hangover for life Prison needle exchange controversy Quit or die, you have another choice Contents matters of substance November 2007 Features Vol 17 No 4 ISSN 1177-200X 02 Cover Story Is alcohol-related brain Mike Webb of the matters of substance is published by the Let’s talk about pot impairment a silent New Zealand Police writes NZ Drug Foundation. All rights reserved. but growing epidemic about a major review of Neither this publication nor any part amongst heavy drinking the Police Act, which is of it may be reproduced without prior permission of the NZ Drug Foundation. New Zealanders? New currently underway, and the research suggests our opportunities this might bring matters of substance invites feedback culture of drunkenness about for harm minimisation and contributions. If you’re interested in may be putting our brains at the frontline of policing. contributing a guest editorial or article, at risk, and most won’t please first contact us: know until it’s too late. [email protected] Marijuana. It’s the most 29 Mythbusters p +64 4 801 6303 widely used and least talked Hard time and about (illicit) recreational Regulars hard numbers Brand development/graphic design drug in New Zealand. In this Origin Design +64 4 801 6644 [email protected] special edition of Matters of 01 The Director’s Cut Substance, we’ve asked Drug Foundation Director interested and interesting NZ Drug Foundation Ross Bell writes about 3rd Floor, 111 Dixon Street people from across the current drug law review in PO Box 3082, Wellington, New Zealand cannabis spectrum to share New Zealand.
    [Show full text]
  • Medical Use of Cannabis in Switzerland: Analysis of Approved Exceptional Licences
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2017 Medical use of cannabis in Switzerland: analysis of approved exceptional licences Kilcher, Gablu ; Zwahlen, Marcel ; Ritter, Christopher ; Fenner, Lukas ; Egger, Matthias Abstract: AIMS OF THE STUDY: In recent years, the Swiss Federal Office of Public Health (FOPH) granted exceptional licenses for the medical use of cannabinoids, typically for 6 months with possible extensions. A systematic review of cannabinoids for medical use commissioned by the FOPH supports the use of cannabinoids for the treatment of chronic pain and spasticity. However, little is known about the patients treated with cannabinoids. We aimed to study medical uses of cannabinoids as part of the FOPH’s programme of exceptional licenses. METHODS: We examined all requests for medical use of cannabinoids sent to FOPH in 2013 and 2014. A standardised data sheet was developed to extract data from the files of approved requests. We extracted the duration of the licence, the yearitwas granted, and the payer of the therapy. At the level of the patient we collected the date of birth, sex, region of residence, diagnosis and the indication. Ethical approval was granted by the Ethics Committee of the Canton of Bern. RESULTS: We analysed 1193 patients licenced for cannabinoid treatment in 2013 or 2014. During 2013, 542 patients were treated under the exceptional licencing programme (332 requesting physicians) compared with 825 in 2014 (446 physicians). Over half of patients (685; 57%) were women. The mean age was 57 years (standard deviation 15.0), chronic pain (49%) and spasticity (40%) were the most common symptoms, and co-medication was reported for 39% of patients.
    [Show full text]